{"id":"augmentin","safety":{"commonSideEffects":[{"rate":"5-10%","effect":"Diarrhea"},{"rate":"3-5%","effect":"Nausea"},{"rate":"1-3%","effect":"Vomiting"},{"rate":"1-3%","effect":"Rash"},{"rate":"1-3%","effect":"Abdominal pain"},{"rate":"0.1-1%","effect":"Allergic reaction/anaphylaxis"}]},"_chembl":null,"_dailymed":{"setId":"59979859-8c9b-4173-a5e3-2e6312fd9d79","title":"AUGMENTIN ES-600 (AMOXICILLIN AND CLAVULANATE POTASSIUM) FOR SUSPENSION [USANTIBIOTICS, LLC\n]"},"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Amoxicillin works by inhibiting bacterial cell wall synthesis through penicillin-binding proteins. Clavulanic acid irreversibly binds to and inactivates beta-lactamase enzymes produced by resistant bacteria, preventing them from destroying amoxicillin and allowing the antibiotic to remain effective against otherwise resistant gram-positive and gram-negative organisms.","oneSentence":"Augmentin combines amoxicillin (a beta-lactam antibiotic) with clavulanic acid (a beta-lactamase inhibitor) to kill bacteria and overcome antibiotic resistance.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:27:55.934Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Bacterial infections of the ear, nose, and throat"},{"name":"Respiratory tract infections"},{"name":"Urinary tract infections"},{"name":"Skin and soft tissue infections"},{"name":"Bone and joint infections"}]},"trialDetails":[{"nctId":"NCT07234448","phase":"NA","title":"Evaluation of the Use of a Probiotic Containing Bifidobacterium Breve PRL2020 in Oral Drops in Preventing Side Effects From Amoxicillin or Amoxicillin/Clavulanic Acid Antibiotic Use","status":"NOT_YET_RECRUITING","sponsor":"Liaquat University of Medical & Health Sciences","startDate":"2025-12-01","conditions":"Antibiotic-associated Diarrhea","enrollment":1000},{"nctId":"NCT05840588","phase":"NA","title":"Effect of Bifidobacterium Breve PRL2020 (an Amoxicillin-clavulanate-resistant Strain) on Gastrointestinal Symptoms and Gut Microbiota Composition in Children Treated With Amoxicillin or Amoxicillin/Clavulanate","status":"COMPLETED","sponsor":"Liaquat University of Medical & Health Sciences","startDate":"2023-11-06","conditions":"Bacterial Infections","enrollment":121},{"nctId":"NCT07233733","phase":"NA","title":"A Clinical Study of Connective Tissue Graft and Enamel Matrix Derivative in the Treatment of Intrabony Periodontal Defects","status":"COMPLETED","sponsor":"Phạm Đình Thiên Khải","startDate":"2024-06-01","conditions":"Periodontal Diseases, Regeneration","enrollment":17},{"nctId":"NCT06850714","phase":"NA","title":"Evaluation of Bifidobacterium Breve PRL2020 in Preventing Antibiotic-Associated Side Effects From Amoxicillin or Amoxicillin/Clavulanic Acid","status":"NOT_YET_RECRUITING","sponsor":"Liaquat University of Medical & Health Sciences","startDate":"2025-02-23","conditions":"Antibiotic Side Effect","enrollment":800},{"nctId":"NCT05804123","phase":"NA","title":"LiveSpo Navax® Supports the Treatment of Acute Rhinosinusitis and Otitis Media","status":"COMPLETED","sponsor":"Anabio R&D","startDate":"2021-10-28","conditions":"Upper Respiratory Tract Infections","enrollment":175},{"nctId":"NCT00836901","phase":"PHASE1","title":"Amoxicillin-Clavulanic Acid 400 Mg-57 mg Chewable Tablets Under Non-Fasting Conditions","status":"COMPLETED","sponsor":"Teva Pharmaceuticals USA","startDate":"2003-09","conditions":"Healthy","enrollment":52},{"nctId":"NCT00835705","phase":"PHASE1","title":"Amoxicillin-Clavulanic Acid 400 Mg-57 mg Chewable Tablets Under Fasting Conditions","status":"COMPLETED","sponsor":"Teva Pharmaceuticals USA","startDate":"2003-09","conditions":"Healthy","enrollment":52},{"nctId":"NCT04600752","phase":"PHASE4","title":"Study to Evaluate the Safety and Clinical Efficacy of Augmentin® Extra Strength-600 in Children With Acute Otitis Media in India","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2022-05-07","conditions":"Otitis Media, Infections, Respiratory Tract, Respiratory Tract Infections","enrollment":310},{"nctId":"NCT00423176","phase":"PHASE3","title":"The Study of Nasonex® Compared With Placebo for the Relief of Symptoms Associated With Acute Bacterial Sinusitis When Used With Antibiotics (Study P04824AM3)","status":"TERMINATED","sponsor":"Organon and Co","startDate":"2006-12","conditions":"Sinusitis","enrollment":237},{"nctId":"NCT06154720","phase":"","title":"Surgical Site Infection After Episiotomy Repair Related to Routine Use of Antibiotic Prophylaxis in Low-Risk Population","status":"COMPLETED","sponsor":"Ain Shams University","startDate":"2022-09-10","conditions":"Surgical Site Infection","enrollment":200},{"nctId":"NCT02567825","phase":"NA","title":"Efficacy of Tympanostomy Tubes for Children With Recurrent Acute Otitis Media","status":"COMPLETED","sponsor":"Alejandro Hoberman","startDate":"2015-11","conditions":"Acute Otitis Media","enrollment":250},{"nctId":"NCT05378022","phase":"NA","title":"Effects of Nasal-spraying LiveSpo Navax in Treatment of Influenza Virus in Children","status":"COMPLETED","sponsor":"National Children's Hospital, Vietnam","startDate":"2020-12-21","conditions":"Acute Respiratory Tract Infections","enrollment":70},{"nctId":"NCT04629378","phase":"PHASE2","title":"Evaluating the EBA of Meropenem With Amoxicillin/Clavulanate and Pyrazinamide or Bedaquiline in Adults With PTB","status":"COMPLETED","sponsor":"TASK Applied Science","startDate":"2020-08-17","conditions":"Tuberculosis","enrollment":22},{"nctId":"NCT02899702","phase":"PHASE4","title":"Effectiveness of Intravenous Immunoglobulins (IVIG) in Toxic Shock Syndromes in Children","status":"WITHDRAWN","sponsor":"Hospices Civils de Lyon","startDate":"2020-09","conditions":"Staphylococcal Infection, Streptococcal Infection","enrollment":""},{"nctId":"NCT02099240","phase":"EARLY_PHASE1","title":"Patients Response to Early Switch To Oral:Osteomyelitis Study","status":"TERMINATED","sponsor":"Julio Ramirez","startDate":"2014-03-06","conditions":"Osteomyelitis","enrollment":11},{"nctId":"NCT01951768","phase":"PHASE4","title":"Efficacy and Safety of Garamycin® Sponge in Diabetic Patients With a Moderate or Severe Foot Ulcer Infection","status":"COMPLETED","sponsor":"University Hospital, Geneva","startDate":"2013-09","conditions":"Diabetic Foot Ulcer","enrollment":88},{"nctId":"NCT04110587","phase":"PHASE4","title":"Hyaluronic Acid Evaluation as Adjuvant to Temporomandibular Joint Arthroscopy","status":"COMPLETED","sponsor":"Universidad Complutense de Madrid","startDate":"2013-12-10","conditions":"Temporomandibular Joint Disc Displacement, Temporomandibular Joint Disorders","enrollment":54},{"nctId":"NCT03702894","phase":"PHASE1","title":"Bioequivalence Study of Clavamox, Film-coated Tablets, 875 mg + 125 mg Pharmtechnology LLC, Belarus), and Augmentin®, Film-coated Tablets, 875 mg + 125 mg (GlaxoSmithKline Trading CJSC, Russia), in Healthy Volunteers Under Fasting Conditions","status":"COMPLETED","sponsor":"Pharmtechnology LLC","startDate":"2018-09-21","conditions":"Bioequivalence","enrollment":56},{"nctId":"NCT03616301","phase":"PHASE1","title":"Bioequivalence Study of Clavamox, Powder for Oral Suspension, 400 mg + 57 mg / 5 ml (Pharmtechnology LLC, Belarus), and Augmentin®, Powder for Oral Suspension, 400 mg + 57 mg / 5 ml (GlaxoSmithKline Trading CJSC, Russia), in Healthy Volunteers Under Fasting Conditions","status":"COMPLETED","sponsor":"Pharmtechnology LLC","startDate":"2018-07-28","conditions":"Bioequivalence","enrollment":56},{"nctId":"NCT01406275","phase":"","title":"Special Drug Use Investigation for CLAVAMOX® (Amoxicillin/Clavulanate) Pediatrics Dry Syrup (Every Indication Excluded Otitis Media)","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2008-01","conditions":"Otitis Maedia","enrollment":363},{"nctId":"NCT01697059","phase":"NA","title":"Initial Antibiotics and Delayed Appendectomy for Acute Appendicitis","status":"COMPLETED","sponsor":"Rhode Island Hospital","startDate":"2012-09","conditions":"Acute Appendicitis","enrollment":73},{"nctId":"NCT01941160","phase":"PHASE1, PHASE2","title":"Effect of a Lacidofil® STRONG in Healthy Adults Taking Antibiotic Treatment","status":"COMPLETED","sponsor":"KGK Science Inc.","startDate":"2013-08","conditions":"Antibiotic Associated Diarrhea","enrollment":160},{"nctId":"NCT00531791","phase":"PHASE3","title":"Effects of Advair® in Outpatients With Chronic Obstructive Pulmonary Disease (COPD) Acute Exacerbation","status":"COMPLETED","sponsor":"Laval University","startDate":"2007-11","conditions":"Chronic Obstructive Pulmonary Disease (COPD)","enrollment":14},{"nctId":"NCT00174694","phase":"PHASE4","title":"CHOOSE : Telithromycin, Acute Bacterial Sinusitis","status":"COMPLETED","sponsor":"Sanofi","startDate":"2004-11","conditions":"Sinusitis","enrollment":298},{"nctId":"NCT00778284","phase":"NA","title":"Bioequivalence Study of Amoxicillin 400 mg/Clavulanic Acid 57 mg Chewable Tablets Under Fed Conditions","status":"COMPLETED","sponsor":"Ranbaxy Laboratories Limited","startDate":"2002-10","conditions":"Healthy","enrollment":40},{"nctId":"NCT00778661","phase":"NA","title":"Bioequivalence Study of Amoxicillin 400 mg/Clavulanic Acid 57 mg Chewable Tablets Under Fasting Conditions","status":"COMPLETED","sponsor":"Ranbaxy Laboratories Limited","startDate":"2002-10","conditions":"Healthy","enrollment":40},{"nctId":"NCT00649831","phase":"PHASE3","title":"A Multicentre, Randomised, Open-Label Study To Compare The Efficacy And Safety Of Azithromycin For 5 Days With Those Of Amoxicillin-Clavulanic Acid In Patients With Chronic Bronchitis","status":"COMPLETED","sponsor":"Pfizer","startDate":"2002-10","conditions":"Bronchitis, Chronic","enrollment":250}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":748,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["laparoscopy","Experimental: Augmentin","Augmentin 3 tablets (Amoxicilin:clavualanate=2:1) bid, for 14days","the reference product"],"phase":"marketed","status":"active","brandName":"Augmentin®","genericName":"Augmentin®","companyName":"Teva Pharmaceuticals USA","companyId":"teva-pharmaceuticals-usa","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Augmentin combines amoxicillin (a beta-lactam antibiotic) with clavulanic acid (a beta-lactamase inhibitor) to kill bacteria and overcome antibiotic resistance. Used for Bacterial infections of the ear, nose, and throat, Respiratory tract infections, Urinary tract infections.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":2,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}